Feasibility Study for Fibroblast Autologous Skin Grafts

Inclusion Criteria: * May be male or female * Must be between 18 years and 65 years of age * In the opinion of the investigator, must be medically able to undergo the administration of study material determined by laboratory tests obtained within 7 days before baseline for which the investigator identified no clinically significant abnormality. * Be able to comprehend the informed consent document and provide consent for participation * Females of childbearing potential must: * have a negative pregnancy test at screening * agree to not become pregnant or breastfeed for the period of the study through 1 month after completion of the study * be willing to use a reliable form of contraception during the study * Have healthy skin as determined by the PI or study Nurse Practitioner. * Be willing and able to comply with the scheduled visits, biopsy/injection procedures, wound care instructions treatment plan, and other study procedures for the duration of the study. Exclusion Criteria: * Having received any investigational drug within 30 days prior to study entry * An allergy history to any study materials including local anesthetic, dimethyl sulfoxide, human albumin, or bovine constituents, or hetastarch * Pregnant, lactating, or trying to become pregnant * A history of keloid formation * An active nonhealing wound * Having a significant medical history that the investigator feels is not safe for study participation (for example, some forms of autoimmune conditions, meta…